BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2011
View Archived Issues
Alzheimer's Drug Discovery Foundation awards drug development grant to Madera Biosciences
Read More
New biomarker described of mortality and hospitalization due to chronic heart failure
Read More
Findings from phase IV ESSENCE-DIABETES study disclosed
Read More
New neuraminidase inhibitors presented by Canadian university
Read More
Novel antibacterial agents synthesized by KBP Biosciences
Read More
Nerviano Medical Sciences discloses new B-raf inhibitors
Read More
NicOx reports novel agents for neuropathic pain
Read More
Boehringer Ingelheim presents novel HCV NS5A inhibitors
Read More
New corticotropin-releasing factor CRF1 receptor antagonists claimed
Read More
Bivalent HPV-16/18 vaccine shows potential against anal HPV infection
Read More
Study identifies new SNPs linked to risk of prostate cancer-specific mortality
Read More
Extended-release tapentadol receives FDA approval for chronic pain
Read More
Boehringer Ingelheim to launch new phase II trial of dabigatran etexilate
Read More
Abbott and Eisai to launch pancreatic digestive enzyme replacement products in Japan
Read More
Astellas Pharma applies for approvals of mirabegron in U.S. and Europe
Read More
Afexa Life Sciences reports encouraging results from pediatric clinical trial of COLD-FX
Read More
Phase III trial compares Ferinject and Venofer in IBD-associated iron deficiency anemia
Read More
Actelion reports results from MUSIC trial of macitentan
Read More
Takeda initiates two phase II trials of TAK-385 in Japan
Read More
Mologen reports results from phase I/II renal cancer trial
Read More
PAION initiates phase Ib study of Solulin
Read More
Novartis receives complete response letter from FDA regarding canakinumab
Read More
Cellestis acquired by QIAGEN
Read More
Berinert for self-administration approved in Europe
Read More
FDA approves Xalkori and companion diagnostic kit
Read More